Fidelity Funds - Switzerland Fund A-DIST-CHFRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 11.3 | 19.3 | -14.2 | 7.5 | -2.5 | |
+/-Cat | 0.9 | -0.7 | -5.4 | -3.4 | 0.6 | |
+/-B’mrk | - | -3.0 | -7.0 | -1.1 | 1.4 | |
Category: Switzerland Equity | ||||||
Category Benchmark: Morningstar Switzerland TME... |
Key Stats | ||
NAV 01/05/2024 | CHF 72.69 | |
Day Change | -0.76% | |
Morningstar Category™ | Switzerland Equity | |
ISIN | LU0054754816 | |
Fund Size (Mil) 31/03/2024 | CHF 242.37 | |
Share Class Size (Mil) 01/05/2024 | CHF 164.92 | |
Max Initial Charge | 5.25% | |
Ongoing Charge 02/02/2024 | 1.92% |
Investment Objective: Fidelity Funds - Switzerland Fund A-DIST-CHF |
The fund aims to achieve capital growth over time. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Andrea Fornoni 01/03/2018 | ||
Alberto Chiandetti 01/03/2018 | ||
Inception Date 13/02/1995 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Switzerland NR CHF | Morningstar Switzerland TME NR CHF |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Fidelity Funds - Switzerland Fund A-DIST-CHF | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Nestle SA | Consumer Defensive | 8.61 |
Novartis AG Registered Shares | Healthcare | 5.28 |
Roche Holding AG | Healthcare | 5.27 |
Lonza Group Ltd | Healthcare | 5.09 |
Givaudan SA | Basic Materials | 4.78 |
Increase Decrease New since last portfolio | ||
Fidelity Funds - Switzerland Fund A-DIST-CHF |